GORDON CARL L

CIK 000128293027 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001282930

Recent Transactions

50 trades

Conversion
BlossomHill Therapeutics, Inc.$BLSM
Series B Preferred Stock
2026-08-10−1,049,283→ 0 total
Conversion
BlossomHill Therapeutics, Inc.$BLSM
Series A Preferred Stock
2026-08-10−1,039,996→ 0 total
Conversion
BlossomHill Therapeutics, Inc.$BLSM
Common Stock
2026-08-10+1,049,283→ 2,089,279 total
Purchase
BlossomHill Therapeutics, Inc.$BLSM
Common Stock
2026-08-10$16.00/sh+625,000→ 2,714,279 total
Conversion
BlossomHill Therapeutics, Inc.$BLSM
Common Stock
2026-08-10+1,039,996→ 1,039,996 total
Award
BlossomHill Therapeutics, Inc.$BLSM
Director Stock Option (Right to Buy)
2026-08-06+23,904→ 23,904 total
Purchase
Scribe Therapeutics, Inc.$SCTX
Common Stock
2026-07-27$15.00/sh+1,000,000→ 1,348,825 total
Conversion
Scribe Therapeutics, Inc.$SCTX
Series B Preferred Stock
2026-07-27−2,065,672→ 0 total
Conversion
Scribe Therapeutics, Inc.$SCTX
Common Stock
2026-07-27+348,825→ 348,825 total
Award
Scribe Therapeutics, Inc.$SCTX
Stock Option (Right to Buy)
2026-07-23+14,725→ 14,725 total
Award
Compass Therapeutics, Inc.$CMPX
Stock Option (Right to Buy)
2026-01-02+90,000→ 90,000 total
Disposition to Issuer
Keros Therapeutics, Inc.$KROS
Common Stock
2025-11-21$17.75/sh−74,465→ 45,057 total
Disposition to Issuer
Keros Therapeutics, Inc.$KROS
Common Stock
2025-11-21$17.75/sh−140,057→ 759,155 total
Award
Keros Therapeutics, Inc.$KROS
Common Stock
2025-06-04+5,250→ 5,250 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2025-06-04+10,500→ 10,500 total
Sale
Compass Therapeutics, Inc.$CMPX
Common Stock
2025-04-09$1.59/sh−3,571,428→ 0 total
Purchase
MBX Biosciences, Inc.$MBX
Common Stock
2025-02-18$10.84/sh+94,100→ 747,887 total
Purchase
MBX Biosciences, Inc.$MBX
Common Stock
2025-02-18$10.84/sh+49,070→ 3,255,000 total
Purchase
MBX Biosciences, Inc.$MBX
Common Stock
2025-02-14$9.85/sh+29,540→ 3,205,930 total
Purchase
MBX Biosciences, Inc.$MBX
Common Stock
2025-02-14$9.90/sh+17,962→ 3,176,390 total
Award
Compass Therapeutics, Inc.$CMPX
Stock Option (Right to Buy)
2025-02-11+40,000→ 40,000 total
Conversion
Lomond Therapeutics Holdings, Inc.
Simple Agreement for Future Equity
2024-11-01−74,613→ 0 total
Award
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$4.00/sh+808,894→ 2,042,400 total
Conversion
Lomond Therapeutics Holdings, Inc.
Simple Agreement for Future Equity
2024-11-01−389,078→ 0 total
Conversion
Lomond Therapeutics Holdings, Inc.
Simple Agreement for Future Equity
2024-11-01−215,146→ 0 total
Conversion
Lomond Therapeutics Holdings, Inc.
Simple Agreement for Future Equity
2024-11-01−323,916→ 0 total
Award
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$4.00/sh+479,736→ 2,522,136 total
Conversion
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$3.60/sh+74,613→ 1,233,506 total
Conversion
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$3.60/sh+389,078→ 928,140 total
Conversion
Lomond Therapeutics Holdings, Inc.
Simple Agreement for Future Equity
2024-11-01−230,753→ 0 total
Conversion
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$3.20/sh+323,916→ 323,916 total
Conversion
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$3.60/sh+230,753→ 1,158,893 total
Award
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$4.00/sh+155,120→ 2,677,256 total
Conversion
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$3.20/sh+215,146→ 539,062 total
Purchase
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16$16.00/sh+500,000→ 3,158,428 total
Purchase
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16$16.00/sh+250,000→ 653,787 total
Conversion
MBX Biosciences, Inc.$MBX
Series A Convertible Preferred Stock
2024-09-16−12,372,634→ 0 total
Conversion
MBX Biosciences, Inc.$MBX
Series C Convertible Preferred Stock
2024-09-16−4,854,368→ 0 total
Conversion
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16+2,658,428→ 2,658,428 total
Conversion
MBX Biosciences, Inc.$MBX
Series B Convertible Preferred Stock
2024-09-16−19,587,284→ 0 total
Conversion
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16+403,787→ 403,787 total
Award
MBX Biosciences, Inc.$MBX
Stock Option (Right to Buy)
2024-09-12+15,963→ 15,963 total
Award
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21+18,500→ 18,500 total
Disposition to Issuer
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21−18,500→ 0 total
Award
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21+30,000→ 30,000 total
Award
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21+18,500→ 18,500 total
Award
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21+26,400→ 26,400 total
Disposition to Issuer
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21−18,500→ 0 total
Disposition to Issuer
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21−30,000→ 0 total
Disposition to Issuer
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21−26,400→ 0 total

Companies

Recent Filings

Address

C/O BLOSSOMHILL THERAPEUTICS, INC. 10255 SCIENCE CENTER DRIVE, SUITE 200

SAN DIEGO, CA, 92121

View on SEC.gov